MiRNAs in Canine and Human Osteosarcoma: A Highlight Review on Comparative Biomolecular Aspects
Open Access
- 18 February 2021
- Vol. 10 (2), 428
- https://doi.org/10.3390/cells10020428
Abstract
Osteosarcoma (OS) is the most frequent primary malignant tumor of bone in humans and animals. Comparative oncology is a field of study that examines the cancer risk and tumor progression across the species. The canine model is ideally suited for translational cancer research. The biological and clinical characteristics of human and canine OS are common to hypothesize as that several living and environmental common conditions shared between the two species can influence some etiopathogenetic mechanisms, for which the canine species represents an important model of comparison with the human species. In the canine and human species, osteosarcoma is the tumor of bone with the highest frequency, with a value of about 80–85% (in respect to all other bone tumors), a high degree of invasiveness, and a high rate of metastasis and malignancy. Humans and dogs have many genetic and biomolecular similarities such as alterations in the expression of p53 and in some types of microRNAs that our working group has already described previously in several separate works. In this paper, we report and collect new comparative biomolecular features of osteosarcoma in dogs and humans, which may represent an innovative update on the biomolecular profile of this tumor.Keywords
This publication has 53 references indexed in Scilit:
- Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancerClinical and Translational Oncology, 2013
- microRNA-9 Suppresses the Proliferation, Invasion and Metastasis of Gastric Cancer Cells through Targeting Cyclin D1 and Ets1PLOS ONE, 2013
- MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcomaOrphanet Journal of Rare Diseases, 2013
- Combinatorial Treatment of DNA and Chromatin-Modifying Drugs Cause Cell Death in Human and Canine Osteosarcoma Cell LinesPLOS ONE, 2012
- miRNA Signatures Associate with Pathogenesis and Progression of OsteosarcomaCancer Research, 2012
- MicroRNA-34a Inhibits the Proliferation and Metastasis of Osteosarcoma Cells Both In Vitro and In VivoPLOS ONE, 2012
- Real-Time PCR-Based Analysis of the Human Bile MicroRNAome Identifies miR-9 as a Potential Diagnostic Biomarker for Biliary Tract CancerPLOS ONE, 2011
- Micro‐RNA profiles in osteosarcoma as a predictive tool for ifosfamide responseInternational Journal of Cancer, 2010
- Hsa-miR-9 methylation status is associated with cancer development and metastatic recurrence in patients with clear cell renal cell carcinomaOncogene, 2010
- miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasisNature, 2010